Header Logo

Connection

BETTY LAMOTHE to Recurrence

Back to Details
This is a "connection" page, showing publications BETTY LAMOTHE has written about Recurrence.
BETTY LAMOTHE
Connection Strength
0.023
Recurrence
  1. A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia. Acta Haematol. 2018; 140(1):30-39.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.